Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
06/07/201722:30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/07/201705:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
05/07/201722:50PR Newswire (US)Oramed Announces Dual-Listing on Tel Aviv Stock ExchangeNASDAQ:ORMPOramed Pharmaceuticals Inc
27/06/201722:45PR Newswire (US)Oramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog CapsuleNASDAQ:ORMPOramed Pharmaceuticals Inc
08/06/201722:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/06/201722:45PR Newswire (US)Oramed to Present at the American Diabetes Association 77th Scientific SessionsNASDAQ:ORMPOramed Pharmaceuticals Inc
18/05/201722:45PR Newswire (US)Oramed to Present at Conferences Next WeekNASDAQ:ORMPOramed Pharmaceuticals Inc
09/05/201722:45PR Newswire (US)Oramed Granted Canadian Patent for GLP-1 Analog CapsuleNASDAQ:ORMPOramed Pharmaceuticals Inc
02/05/201722:45PR Newswire (US)Oramed Receives Israel Regulatory Approval to Conduct Human Study for New Oral Leptin CapsuleNASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/201722:30PR Newswire (US)Oramed Granted European Patent for Combination Oral Insulin and GLP-1 Analog CapsuleNASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/201707:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
20/04/201707:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/04/201707:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/04/201706:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ORMPOramed Pharmaceuticals Inc
06/04/201706:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
04/04/201722:45PR Newswire (US)Journal of Diabetes Science and Technology Publishes Scientific Paper Authored by Oramed ScientistsNASDAQ:ORMPOramed Pharmaceuticals Inc
22/03/201723:45PR Newswire (US)Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017NASDAQ:ORMPOramed Pharmaceuticals Inc
22/03/201703:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
22/03/201701:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ORMPOramed Pharmaceuticals Inc
22/03/201700:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
21/03/201723:45PR Newswire (US)Oramed Appoints Dr. Ronald Law as Chief Strategy OfficerNASDAQ:ORMPOramed Pharmaceuticals Inc
03/03/201707:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
03/03/201707:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP